Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus
Sponsored by SCYNEXIS, Inc.
Active
$243.3K Funding
3 People
External
Related Topics
candidemia,
invasive candidiasis,
treatment regimens,
echinocandin,
ibrexafungerp
People
Tirdad Zangeneh
Co-Investigator (COI)
Medicine
﹒Professor
Jose Elizondo
(CD)
Medicine
﹒Research Program Administration Officer III
Martha Barron
(CD)
Medicine
﹒Research Program Administration Officer III
